Precision Care™ Cancer Insurance is designed to help policyholders faced with a cancer diagnosis afford and have access to groundbreaking treatment advancements which may not be covered by other insurance. Precision Care™ gives Policyholders access to TGen’s world class Cancer Physicians and to TGen’s cutting-edge genomic sequencing services while providing cash to pay for these services and the high costs of today’s specialized cancer treatments. For more information on Precision Care™, visit: outsmartmycancer.com.
TGen, the Translational Genomics Research Institute, is an affiliate of City of Hope and is a nonprofit medical research institute. TGen conducts groundbreaking research that unravels the genetic components of common and complex diseases for life-changing results. TGen’s internationally-recognized experts are innovators in clinical genomic testing and pioneers in precision medicine. Their genomic testing explores a patient’s genomic uniqueness in ways unimaginable just a few short years ago. This research helps them set a course of treatment that may not be right for everyone. but is just right for you. For more information on TGen, visit: www.tgen.org .
GTL’s Precision Care™ will not only pay for access to TGen’s genomic sequencing services, but both you and your doctor will have access to one-on-one consultations with TGen oncology experts to help make sense of your sequencing results and treatment recommendations.
GTL’s Precision Care™ Cancer Insurance policy provides Policyholders with a choice of lump sum benefits up to $50,000 to help pay for other medical and non-medical expenses.
TGen looks at 19,000 genes vs average of 400 genes for competitors.